Aditya Shreenivas, M.D., M.S.
- Gastrointestinal Cancers
- Colorectal Cancer
- Head and Neck Cancers
- Assistant Professor, Department of Medical Oncology & Therapeutics Research
Board-certified in hematology and oncology, Aditya Shreenivas, M.D., M.S., takes an individualized approach to treating cancer with leading-edge options, with a particular focus on gastrointestinal cancers and head and neck cancers. As a researcher, he focuses on studying innovative therapeutics and pioneering new approaches to precision medicine.
Dr. Shreenivas was inspired to become a doctor by his grandfather – a physician who founded India’s Indira Gandhi Institute of Cardiology – and his mother, a renowned obstetrician and gynecologist. He earned his medical degree at JSS Medical School in Mysuru, India, then completed a residency in internal medicine at Bronx-Lebanon Medical Center and a fellowship in hematology-oncology at Icahn School of Medicine at Mount Sinai, where he also earned a master’s degree in clinical research.
Dr. Shreenivas will also be affiliated with City of Hope's experimental therapeutics and early drug development program. He believes in the concept of vertical research, and the overall thrust of his research work has been focused on creating a small but significant impacts in the field of oncology. Dr. Shreenivas remains committed to a career focused on symptom management, experimental therapeutics, and precision medicine. He has co-authored several peer-reviewed articles, which have been published in journals like CA: A Cancer Journal for Clinicians and JCO-Precision Oncology, European Journal of Cancers and Blood, among others.
Before joining City of Hope, Dr. Shreenivas was an assistant professor of hematology-oncology at the Medical College of Wisconsin in Milwaukee, where he specialized in head and neck, gastrointestinal and rare cancers. Actively involved in clinical and translational research, he has grant funding from NRG Oncology and served as principal investigator of multiple industry-sponsored and investigator-initiated clinical trials.
Location
Duarte Cancer Center
Duarte, CA 91010
Education & Experience
Board Certifications
- 2018, American Board of Internal Medicine, Hematology
- 2018, American Board of Internal Medicine, Oncology
- 2015, American Board of Internal Medicine, certified
Degrees
- 2018, Master of Science, Clinical Research, Icahn School of Medicine, New York, NY
- 2010, Doctor of Medicine, JSS Medical College, Mysore, India
Fellowship
- 2018, Fellowship, Hematology-Oncology, Mt. Sinai Medical Center, Icahn School of Medicine, New York, NY
Residency
- 2015, Residency, BronxCare Health System, Bronx, NY
Internship
- 2013, Internship, BronxCare Health System, Bronx, NY
Professional Experience
- 2024-Present, Assistant Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
- 2019-2024, Assistant Professor, Department of Medical Oncology, Medical College of Wisconsin, Milwaukee, WI
Awards & Memberships
Awards
- 2023, Listed among Milwaukee’s top oncologists in 2022 in the June 2023 edition of The Waiting Room Magazine
- 2020, NRG NCORP pilot grant recipient
- 2018, Awarded Master of Science in Clinical Research Best Thesis Award for the academic year at the Mount, Sinai Achievement Award Ceremony
Memberships
- Young Investigator Committee Head and Neck Cancer International Group
- Alliance Gastrointestinal Cancer Committee
- NRG Head & Neck Rare Cancer Committee
- Alliance Symptom Intervention Committee
- ECOG Symptom Intervention Committee
Publications
- Baliga S, Abou-Foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Blakaj D, Brennan S, Brunet A, De Oliveira TB, Burtness B, Maseda AC, Chow VL, Chua ML, de Ridder M, Garikipati S, Hanai N, Ho FCH, Huang SH, Kiyota N, Klinghammer K, Kowalski LP, Kwong DL, McDowell LJ, Merlano MC, Nair S, Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database. Economopoulou P, Overgaard J, Psyrri A, Tribius S, Waldron J, Yom SS, Mehanna H. Eur J Cancer. 2024 May;203:114038. doi: 10.1016/j.ejca.2024.114038. Epub 2024 Mar 30. PMID: 38579517
- Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HA Type I interferon signaling promotes radioresistance in head and neck cancer. Transl Cancer Res. 2024 May 31;13(5):2535-2543. doi: 10.21037/tcr-23-2104. Epub 2024 May 13. PMID: 38881922
- Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 1;10(7):896-904. doi: 10.1001/jamaoncol.2024.1143. PMID: 38780927 Clinical Trial.
- Limaye S, Menon M, Singh S, Kataria P, Shreenivas A, Datar R, Patil D, Kumar P, Shah N, Sheth H, Sneha S, Madre C, Deshpande R, Menon NK, Dandekar P, Haribhakti V.
Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy. J Immunother Precis Oncol. 2024 Aug 19;7(3):171-177. doi: 10.36401/JIPO-24-1. eCollection 2024 Aug. PMID: 39220001 - Thapa B; Shreenivas A; Bylow K; Chen H; George B; Kurzrock R. Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases Journal of Immunotherapy and Precision Oncology J Immunother Precis Oncol. 2024 Nov 1;7(4):308-313. doi: 10.36401/JIPO-24-13. eCollection 2024 Nov. PMID: 39524464
- Sangro B, Kudo M , Shreenivas A (listed among investigators), Lencioni R. Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study. Lancet 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. DOI: 10.1016/S0140-6736(24)02551-0 PMID: 39798579
- Shreenivas A., Vissers E., Ajani J. Barriers to clinical implementation for novel therapies and biomarker testing in the community practice oncology setting: A CLDN18.2 case study currently in revision in the Oncologist 2025
- Cohen SA, Aushev VN, Laliotis G, Jabbal IS, Nagarajan A, Wang C, Fakih M, Sharif S, Alyunis F, Tejani MA, Alqahtani A, Marshall J, Chang J, Botta G, Manage K, George GV, Sharma S, Malhotra M, Chandana S, Mehler S, Somer BG, Babadi E, Wu C, Hanna D, Chidharla A, Kasi A, Vosoughi E, Dayyani F, Pedersen K, Briski RE, Azzi G, Katiyar V, Chan A, Sharma V, Shreenivas A, Chakrabarti S, Fuqua J, Malla M, Polite B, Bent AH, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Kopetz S. Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer. Ann Surg. 2025 Aug 7. doi: 10.1097/SLA.0000000000006887. PMID: 40772634
- Gianchandani A. , Shreenivas A., Kumar P, Limaye S. Exceptional Response to Immunotherapy-based Treatment in compound EGFR-Mutated Oligometastatic Pulmonary Sarcomatoid Carcinoma: A Case Report. J Immunother Precis Oncol. 2025 Aug 22;8(3):206-211. doi: 10.36401/JIPO-25-7. eCollection 2025 Aug. PMID: 40927311
- Limaye S, Shreenivas A, Patil D, Sambath J, George IA, Parab A, Datta A, Jain P, Singh S, Madre C, Kataria P, Shah D, Shah N, Deshpande R, Datar R, Kumar P. Liquid biopsy- A pivotal test to help navigate clinical decisions at a precision center in India! J Liq Biopsy. 2025 Aug 9;9:100323. doi: 10.1016/j.jlb.2025.100323. eCollection 2025 Sep. PMID: 40919127
- Reyes A, Maroongroge S, Afkhami M, Villaflor V, Amini A, Sampath S, Maghami E, Gernon T, Patel K, Li X, Shreenivas A. Evaluating Clinical Factors Including HPV Clearance on Survival Outcomes in HPV+ Oropharyngeal Carcinoma. Cancers (Basel). 2025 Aug 27;17(17):2802. doi: 10.3390/cancers17172802. PMID: 40940899
To view more publications, please click here.